Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Perrigo reported $140.6M in EBITDA for its fiscal quarter ending in March of 2023.

Ebitda Change
Abbott ABT:US USD 2.33B 13M
Bayer BAYN:GR EUR 4.47B 1.31B
Bristol-Myers Squibb BMY:US USD 5.43B 772M
Catalent CTLT:US USD 242M 85M
Dr.Reddys Laboratories DRRD:IN INR 16.11B 3.41B
Eli Lilly LLY:US USD 1.96B 528.3M
Endo International ENDP:US USD 181.9M 38.32M
Horizon Pharma HZNP:US USD 133.36M 180.38M
J&J JNJ:US USD 9B 934.8M
Nestle NESN:VX 9.98B 615M
Pacira PCRX:US USD 28.64M 16.13M
Perrigo PRGO:US USD 140.6M 800K
Pfizer PFE:US USD 8.01B 683M
Phibro Animal Health PAHC:US USD 27.04M 3.87M
Reckitt Benckiser Group PLC RB/:LN GBP 1.9B 54M
Supernus Pharmaceuticals SUPN:US USD 25.78M 30.06M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 1.08B 226M
Zoetis ZTS:US USD 877M 60M